Tirzepatide is a next-generation dual-action weight loss treatment that targets both GLP-1 and GIP receptors for enhanced appetite control and metabolic improvement. It’s designed for patients seeking more advanced support in their weight loss journey, helping to reduce cravings and promote long-term success.